9 results on '"Molina, María"'
Search Results
2. Genomic study of dilated cardiomyopathy in a group of Mexican patients using site‐directed next generation sequencing.
- Author
-
Carnevale, Alessandra, Rosas‐Madrigal, Sandra, Rosendo‐Gutiérrez, Rigoberto, López‐Mora, Enrique, Romero‐Hidalgo, Sandra, Avila‐Vazzini, Nydia, Jacobo‐Albavera, Leonor, Domínguez‐Pérez, Mayra, Vargas‐Alarcón, Gilberto, Pérez‐Villatoro, Fernando, Navarrete‐Martínez, Juana Inés, and Villarreal–Molina, María Teresa
- Subjects
MEXICANS ,DILATED cardiomyopathy ,RECESSIVE genes ,MOLECULAR diagnosis ,HEART failure ,YOUNG adults ,ISCHEMIC preconditioning - Abstract
Background: Dilated cardiomyopathy (DCM) is a major cause of nonischemic heart failure and death in young adults. Next generation sequencing (NGS) has become part of the diagnostic workup in idiopathic and familial DCM. More than 50 DCM genes have been identified, revealing great molecular heterogeneity and variable diagnostic yield. Interpretation of variant pathogenicity is challenging particularly in underrepresented populations, as pathogenic variant databases include studies mainly from European/Caucasian populations. To date, no studies on genomic diagnosis of DCM have been conducted in Mexico. Methods: We recruited 55 unrelated DCM patients, 22 familial (F‐DCM), and 33 idiopathic (I‐DCM), and performed site‐directed NGS seeking causal mutations. Diagnostic yield was defined as the proportion of individuals with at least one pathogenic (P) or likely pathogenic (LP) variant in DCM genes. Results: Overall diagnostic yield was 47.3%, and higher in F‐DCM (63.6%) than in I‐DCM (36.4%, p = 0.047). Overall, NGS disclosed 41 variants of clinical interest (61.0% novel), 27 were classified as P/LP and 14 of unknown clinical significance. Of P/LP variants, 10 were A‐band region TTN truncating variants, five were found in DSP (18.5%), five in MYH7 (18.5%), two in LMNA (7.4%), and one in RBM20, ABCC9, FKTN, ACTA1, and TNNT2. NGS findings suggested autosomal recessive inheritance in three families, two with DSP loss of function mutations in affected individuals. The increasing number of mutation reports in DCM, increasing knowledge on the functional consequences of mutations, mutational hotspots and functional domains of DCM‐related proteins, the recent refinement ACMG/ClinGen Guidelines, and co‐segregation analysis in DCM families helped increase the diagnostic yield. Conclusion: This is the first NGS study performed in a group of Mexican DCM patients, contributing to understand the mutational spectrum and complexity of DCM molecular diagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
3. Fanconi Anemia Patients from an Indigenous Community in Mexico Carry a New Founder Pathogenic Variant in FANCG.
- Author
-
Reyes, Pedro, García-de Teresa, Benilde, Juárez, Ulises, Pérez-Villatoro, Fernando, Fiesco-Roa, Moisés O., Rodríguez, Alfredo, Molina, Bertha, Villarreal-Molina, María Teresa, Meléndez-Zajgla, Jorge, Carnevale, Alessandra, Torres, Leda, and Frias, Sara
- Subjects
FANCONI'S anemia ,GENETIC testing ,CHROMOSOME abnormalities ,NUCLEOTIDE sequencing ,GENETIC disorders ,COMMUNITIES ,HAPLOTYPES ,PHENOTYPES - Abstract
Fanconi anemia (FA) is a rare genetic disorder caused by pathogenic variants (PV) in at least 22 genes, which cooperate in the Fanconi anemia/Breast Cancer (FA/BRCA) pathway to maintain genome stability. PV in FANCA, FANCC, and FANCG account for most cases (~90%). This study evaluated the chromosomal, molecular, and physical phenotypic findings of a novel founder FANCG PV, identified in three patients with FA from the Mixe community of Oaxaca, Mexico. All patients presented chromosomal instability and a homozygous PV, FANCG: c.511-3_511-2delCA, identified by next-generation sequencing analysis. Bioinformatic predictions suggest that this deletion disrupts a splice acceptor site promoting the exon 5 skipping. Analysis of Cytoscan 750 K arrays for haplotyping and global ancestry supported the Mexican origin and founder effect of the variant, reaffirming the high frequency of founder PV in FANCG. The degree of bone marrow failure and physical findings (described through the acronyms VACTERL-H and PHENOS) were used to depict the phenotype of the patients. Despite having a similar frequency of chromosomal aberrations and genetic constitution, the phenotype showed a wide spectrum of severity. The identification of a founder PV could help for a systematic and accurate genetic screening of patients with FA suspicion in this population. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
4. Querétaro: La difícil construcción de identidad urbana.
- Author
-
Guzmán Molina, María Ángeles
- Subjects
- *
POPULATION , *ORGANIZATION , *PLURALISM - Abstract
Querétaro city has registered a high population growth since the 70's. This growth, in Querétaro as well as in other cities of the country, is associated to the industrial growth. Within the national context, some organizations appeared; they widened the pluralism of the participation of social organizations. Nevertheless, the same didn't happen in Querétaro. It is intended, in this article, to explain why. The particular formation of the city determined the late formation of urban identities and this, plus the lack of political choices, explains the non-existence of movilization. [ABSTRACT FROM AUTHOR]
- Published
- 2002
5. Native American ancestry significantly contributes to neuromyelitis optica susceptibility in the admixed Mexican population.
- Author
-
Romero-Hidalgo S, Flores-Rivera J, Rivas-Alonso V, Barquera R, Villarreal-Molina MT, Antuna-Puente B, Macias-Kauffer LR, Villalobos-Comparán M, Ortiz-Maldonado J, Yu N, Lebedeva TV, Alosco SM, García-Rodríguez JD, González-Torres C, Rosas-Madrigal S, Ordoñez G, Guerrero-Camacho JL, Treviño-Frenk I, Escamilla-Tilch M, García-Lechuga M, Tovar-Méndez VH, Pacheco-Ubaldo H, Acuña-Alonzo V, Bortolini MC, Gallo C, Bedoya G, Rothhammer F, González-Jose R, Ruiz-Linares A, Canizales-Quinteros S, Yunis E, Granados J, and Corona T
- Subjects
- Case-Control Studies, Female, Gene Frequency, Humans, Male, Mexico epidemiology, Aquaporin 4 genetics, Genetic Predisposition to Disease, HLA Antigens genetics, Neuromyelitis Optica epidemiology, Neuromyelitis Optica genetics, American Indian or Alaska Native genetics
- Abstract
Neuromyelitis Optica (NMO) is an autoimmune disease with a higher prevalence in non-European populations. Because the Mexican population resulted from the admixture between mainly Native American and European populations, we used genome-wide microarray, HLA high-resolution typing and AQP4 gene sequencing data to analyze genetic ancestry and to seek genetic variants conferring NMO susceptibility in admixed Mexican patients. A total of 164 Mexican NMO patients and 1,208 controls were included. On average, NMO patients had a higher proportion of Native American ancestry than controls (68.1% vs 58.6%; p = 5 × 10
-6 ). GWAS identified a HLA region associated with NMO, led by rs9272219 (OR = 2.48, P = 8 × 10-10 ). Class II HLA alleles HLA-DQB1*03:01, -DRB1*08:02, -DRB1*16:02, -DRB1*14:06 and -DQB1*04:02 showed the most significant associations with NMO risk. Local ancestry estimates suggest that all the NMO-associated alleles within the HLA region are of Native American origin. No novel or missense variants in the AQP4 gene were found in Mexican patients with NMO or multiple sclerosis. To our knowledge, this is the first study supporting the notion that Native American ancestry significantly contributes to NMO susceptibility in an admixed population, and is consistent with differences in NMO epidemiology in Mexico and Latin America.- Published
- 2020
- Full Text
- View/download PDF
6. Influence of Genetic and Non-Genetic Risk Factors for Serum Uric Acid Levels and Hyperuricemia in Mexicans.
- Author
-
Rivera-Paredez B, Macías-Kauffer L, Fernandez-Lopez JC, Villalobos-Comparán M, Martinez-Aguilar MM, de la Cruz-Montoya A, Ramírez-Salazar EG, Villamil-Ramírez H, Quiterio M, Ramírez-Palacios P, Romero-Hidalgo S, Villarreal-Molina MT, Denova-Gutiérrez E, Flores YN, Canizales-Quinteros S, Salmerón J, and Velázquez-Cruz R
- Subjects
- ATP Binding Cassette Transporter, Subfamily G, Member 2 genetics, Adolescent, Adult, Child, Female, Genome-Wide Association Study, Glucose Transport Proteins, Facilitative genetics, Humans, Male, Mexico epidemiology, Middle Aged, Neoplasm Proteins genetics, Polymorphism, Single Nucleotide genetics, Young Adult, Hyperuricemia blood, Hyperuricemia epidemiology, Hyperuricemia genetics, Uric Acid blood
- Abstract
Risk of hyperuricemia is modified by genetic and environmental factors. Our aim was to identify factors associated with serum uric acid levels and hyperuricemia in Mexicans. A pilot Genome-wide association study GWAS was performed in a subgroup of participants ( n = 411) from the Health Workers Cohort Study (HWCS). Single nucleotide polymorphisms (SNPs) associated with serum uric acid levels were validated in all the HWCS participants ( n = 1939) and replicated in independent children ( n = 1080) and adult ( n = 1073) case-control studies. The meta-analysis of the whole HWCS and replication samples identified three SLC2A9 SNPs: rs1014290 ( p = 2.3 × 10
-64 ), rs3775948 ( p = 8.2 × 10-64 ) and rs11722228 ( p = 1.1 × 10-17 ); and an ABCG2 missense SNP, rs2231142 ( p = 1.0 × 10-18 ). Among the non-genetic factors identified, the visceral adiposity index, smoking, the metabolic syndrome and its components (waist circumference, blood pressure, glucose and hyperlipidemia) were associated with increased serum uric acid levels and hyperuricemia ( p < 0.05). Among the female HWCS participants, the odds ratio for hyperuricemia was 1.24 (95% CI, 1.01-1.53) per unit increase in soft drink consumption. As reported in other studies, our findings indicate that diet, adiposity and genetic variation contribute to the elevated prevalence of hyperuricemia in Mexico.- Published
- 2019
- Full Text
- View/download PDF
7. [Biopsychosocial profile of the very old in Colima (80+)].
- Author
-
Molina MÁ and Fernández-Ballesteros R
- Subjects
- Activities of Daily Living, Female, Humans, Male, Mexico, Aged, 80 and over psychology, Geriatric Assessment
- Published
- 2012
- Full Text
- View/download PDF
8. Methylenetetrahydrofolate reductase C677T and glutathione S-transferase P1 A313G are associated with a reduced risk of preeclampsia in Maya-Mestizo women.
- Author
-
Canto P, Canto-Cetina T, Juárez-Velázquez R, Rosas-Vargas H, Rangel-Villalobos H, Canizales-Quinteros S, Velázquez-Wong AC, Villarreal-Molina MT, Fernández G, and Coral-Vázquez R
- Subjects
- Adolescent, Adult, Case-Control Studies, Female, Gene Frequency genetics, Genetic Predisposition to Disease genetics, Genotype, Humans, Mexico, Pre-Eclampsia ethnology, Pregnancy, Glutathione S-Transferase pi genetics, Methylenetetrahydrofolate Reductase (NADPH2) genetics, Polymorphism, Genetic genetics, Pre-Eclampsia genetics
- Abstract
Preeclampsia, a common complication of pregnancy, is characterized by elevated blood pressure and proteinuria developing after 20 weeks' gestational age. Susceptibility to this syndrome is believed to have a genetic component. The aim of this study was to investigate whether or not the 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T and glutathione S-transferase P1 (GSTP1) A313G polymorphisms are associated with preeclampsia in Maya-Mestizo women. A case-control study was performed, in which 125 preeclamptic patients and 274 healthy controls were genotyped for the MTHFR C677T and GSTP1 A313G polymorphisms by real-time PCR allelic discrimination. Allele and genotype frequencies were compared using the chi2 tests. The MTHFR 677T allele and the 677TT genotype were significantly more frequent in the controls, suggesting an association with a decreased risk of preeclampsia (p = 0.017 and p = 0.007, respectively). Similarly, GSTP1 313GG/GC genotypes and the G allele were more frequent in controls, showing a significant association with reduced risk of preeclampsia (p = 0.008 and p = 0.013, respectively). Our results suggest, for the first time, that the MTHFR 677T and GSTP1 313G polymorphisms confer a significantly decreased risk of developing preeclampsia in the Mexican Maya-Mestizo population.
- Published
- 2008
- Full Text
- View/download PDF
9. Founder effect for the Ala431Glu mutation of the presenilin 1 gene causing early-onset Alzheimer's disease in Mexican families.
- Author
-
Yescas P, Huertas-Vazquez A, Villarreal-Molina MT, Rasmussen A, Tusié-Luna MT, López M, Canizales-Quinteros S, and Alonso ME
- Subjects
- Adult, Aged, Aged, 80 and over, Alzheimer Disease etiology, Apolipoproteins E genetics, Case-Control Studies, DNA Mutational Analysis, Female, Gene Frequency, Genetic Testing, Humans, Male, Mexico epidemiology, Middle Aged, Polymorphism, Genetic, Alzheimer Disease genetics, Founder Effect, Genetic Predisposition to Disease, Mutation, Missense, Presenilin-1 genetics
- Abstract
The etiology of Alzheimer's disease (AD) is complex. To date, molecular genetic studies in several families affected with AD have identified three genes associated with highly penetrant early-onset AD: Presenilin 1 (PSEN1), Presenilin 2 (PSEN2) and beta-amyloid precursor protein (APP); and one gene (apolipoprotein E) associated with late-onset AD. Molecular analysis of the PSEN1 gene was performed by direct sequencing of genomic DNA. The possible founder effect was investigated analyzing two highly polymorphic microsatellite markers flanking the PSEN1 gene. Twelve unrelated Mexican families with early-onset AD were analyzed. The Ala431Glu mutation in exon 12 of PSEN1 was found in nine (75%) of these families, which segregated showing autosomal dominant inheritance. Because all families bearing the mutation are from the State of Jalisco (located in Western Mexico), a founder effect was hypothesized. Microsatellite haplotype analysis suggested a common ancestor in these nine kindreds. In conclusion, the Ala431Glu mutation is a prevalent cause of early-onset familial Alzheimer's disease in families from the State of Jalisco, Mexico. Genetic evidence supports that it is a founder mutation descending from a single common ancestor. These findings have important implications for prompt diagnosis and genetic counseling for Mexican patients with familial AD from Jalisco.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.